Post-Mohs Bleeding Risk in Patients on Ibrutinib for CLL Studied Post-Mohs Bleeding Risk in Patients on Ibrutinib for CLL Studied

Two studies evaluated the risk, with results indicating that holding the treatment before and after surgery helps reduce the risk for bleeding.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Dermatology News Source Type: news